Procter & Gamble Hygiene and Health Care Ltd. announced today its financial results for the quarter ended September 30, 2022. In a challenging cost and operating environment, the company delivered sales of ₹ 1045 crores, down 1% vs year ago, due to post-Covid normalization of demand. Profit After Tax (PAT) stood at ₹154 crores, down 29% vs year ago, behind top-line impact and significant effect of commodity cost inflation. Compared to the corresponding pre-covid quarter three years ago, company sales are up 23% and PAT is up 12%. The company continues to maintain market share leadership across both Feminine Hygiene and Healthcare categories.
LV Vaidyanathan, Managing Director, Procter & Gamble Hygiene and Health Care Ltd. shared, "In a challenging macro-economic environment, we delivered resilient results in the quarter by focusing on our integrated growth strategies. We believe they remain the right strategies to navigate through the near-term challenges and help us deliver in line with our aim to drive balanced growth."
Shares of Procter & Gamble Health Limited was last trading in BSE at Rs. 4233.45 as compared to the previous close of Rs. 4098.15. The total number of shares traded during the day was 391 in over 221 trades.
The stock hit an intraday high of Rs. 4270.00 and intraday low of 4104.95. The net turnover during the day was Rs. 1640338.00.